Anaplastic Astrocytoma Clinical Trials

128 clinical trials for Anaplastic Astrocytoma across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion — RECRUITING · PHASE1
• Targeted Pediatric High-Grade Glioma Therapy — RECRUITING
• Loupe-Based Intraoperative Fluorescence Imaging — RECRUITING
• Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA — RECRUITING · PHASE1
• Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant — RECRUITING · PHASE2
• DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma — RECRUITING · PHASE2
• A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma — RECRUITING · PHASE1
• Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA — RECRUITING · PHASE2
• HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM — RECRUITING · PHASE1
• Study of Pembrolizumab and M032 (NSC 733972) — RECRUITING · PHASE1
• Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms — RECRUITING · PHASE1
• Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age — RECRUITING · PHASE1
• A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF EFLORNITHINE WITH LOMUSTINE COMPARED TO LOMUSTINE ALONE IN PATIENTS WITH ANAPLASTIC ASTROCYTOMA THAT PROGRESS/RECUR AFTER IRRADIATION AND ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY - STELLAR STUDY — RECRUITING · PHASE3
• PHASE 2/3 RANDOMIZED, OPEN-LABEL STUDY OF TOCA 511, A RETROVIAL REPLICATING VECTOR, COMBINED WITH TOCA FC VERSUS STANDARD OF CARE IN SUBJECTS UNDERGOING PLANNED RESECTION FOR RECURRENT GLIOBLASTOMA OR ANAPLASTIC ASTROCYTOMA." — RECRUITING · PHASE2
• A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas — ACTIVE_NOT_RECRUITING · PHASE1
• Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma — ACTIVE_NOT_RECRUITING · PHASE2
• Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations — ACTIVE_NOT_RECRUITING · PHASE2
• Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma — ACTIVE_NOT_RECRUITING · PHASE2
• Pediatric Long-Term Follow-up and Rollover Study — ACTIVE_NOT_RECRUITING · PHASE4
• A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma — ACTIVE_NOT_RECRUITING · PHASE1
• Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma — SUSPENDED · PHASE1
• Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma — WITHDRAWN · PHASE2
• Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma — ACTIVE_NOT_RECRUITING
• Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors — TERMINATED
• Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas — ACTIVE_NOT_RECRUITING
• Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401) — COMPLETED · PHASE1
• INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas — COMPLETED · PHASE1
• Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas — TERMINATED
• Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma — COMPLETED · PHASE1
• Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors — TERMINATED · PHASE2
• Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG — TERMINATED · PHASE2
• Dendritic Cell Vaccine for Patients With Brain Tumors — COMPLETED · PHASE2
• SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors — COMPLETED · PHASE1
• Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children — COMPLETED · PHASE1
• Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma — COMPLETED · PHASE2
• Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas — OTHER · NA
• Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas — COMPLETED · PHASE1
• HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors — COMPLETED · PHASE1
• Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors — COMPLETED · PHASE2
• Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma — TERMINATED · PHASE1
• Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas — TERMINATED · PHASE1
• Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas — COMPLETED · PHASE1
• Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection — TERMINATED · PHASE1
• Quality of Life and Patient Needs in Advanced High Grade Gliomas — COMPLETED
• Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas — COMPLETED · PHASE1
• Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2 — TERMINATED · PHASE1
• Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas — TERMINATED · PHASE1
• 3D Prediction of Patient-Specific Response — OTHER
• Immunophenotyping From Blood of Patients With Malignant Gliomas — COMPLETED
• Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas — COMPLETED · PHASE2

Refine this search